SCHEMBL19166643

SCHEMBL19166643

c1ccc(-c2nc(-c3ccc(-c4ncncn4)cc3)nc(-c3cc(-c4ccc5oc6ccccc6c5c4)cc(-c4ccc5oc6ccccc6c5c4)c3)n2)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PLA2G2A P14555 4/20 0.40
▸ PLA2G4A P47712 4/20 0.40
▸ PLA2G10 O15496 1/20 0.40
▸ MAPT P10636 6/20 0.38
▸ KMT2A Q03164 4/20 0.38
▸ ALDH1A1 P00352 3/20 0.38
▸ HPGD P15428 3/20 0.38
▸ MEN1 O00255 3/20 0.38
▸ NPC1 O15118 2/20 0.38
▸ KDM4E B2RXH2 1/20 0.38
▸ RAB9A P51151 1/20 0.38
▸ SMN1; SMN2 Q16637 1/20 0.38
▸ CHEK2 O96017 1/20 0.38
▸ LMNA P02545 2/20 0.36
▸ CASP3 P42574 1/20 0.36
▸ SENP7 Q9BQF6 1/20 0.36
▸ SENP6 Q9GZR1 1/20 0.36
▸ AHR P35869 1/20 0.35
▸ TSHR P16473 2/20 0.34
▸ POLB P06746 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19165223 0.99 PLA2G2A (0.42) PLA2G2APLA2G4APLA2G10MAPTKMT2A
SCHEMBL19165369 0.94 KMT2A (0.40) PLA2G2APLA2G4APLA2G10MAPTKMT2A
SCHEMBL19166627 0.91 KMT2A (0.40) PLA2G2APLA2G4APLA2G10MAPTKMT2A
SCHEMBL19166444 0.91 KMT2A (0.40) PLA2G2APLA2G4APLA2G10MAPTKMT2A
SCHEMBL15501324 0.91 PLA2G2A (0.47) PLA2G2APLA2G4APLA2G10MAPTKMT2A
SCHEMBL21305053 0.91 PLA2G2A (0.47) PLA2G2APLA2G4APLA2G10MAPTKMT2A
SCHEMBL15501323 0.91 PLA2G2A (0.47) PLA2G2APLA2G4APLA2G10MAPTKMT2A
SCHEMBL19165836 0.90 PLA2G2A (0.40) PLA2G2APLA2G4APLA2G10MAPTKMT2A
SCHEMBL19165798 0.90 MEN1 (0.41) PLA2G2APLA2G4APLA2G10MAPTKMT2A
SCHEMBL19165444 0.90 MAPT (0.45) PLA2G2APLA2G4APLA2G10MAPTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10784446-B2 Compound, organic electroluminescence element material, organic electroluminescence element and electronic device IDEMITSU KOSAN CO., LTD. (JP) 2020-09-22 — — US disclosed
US-20170213983-A1 COMPOUND, ORGANIC ELECTROLUMINESCENCE ELEMENT MATERIAL, ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2017-07-27 — — US disclosed
US-20170213983-A1 COMPOUND, ORGANIC ELECTROLUMINESCENCE ELEMENT MATERIAL, ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2017-07-27 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10784446-B2 Compound, organic electroluminescence element material, organic electroluminescence element and electronic device L1CAM, SOD1, OR10J3 PLA2G2A 3552/4885PLA2G4A 4204/4885PLA2G10 2607/4885
US-20170213983-A1 COMPOUND, ORGANIC ELECTROLUMINESCENCE ELEMENT MATERIAL, ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE L1CAM, SOD1, OR10J3 PLA2G2A 3552/4885PLA2G4A 4204/4885PLA2G10 2607/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback